The new application relates to how Akari’s novel PH1 payload demonstrates its ability to modulate the spliceosome to disrupt ...

Through the Bio Village 2.0 initiative, Daspara, in Tripura, has become a model for rural sustainable practices and renewable ...

Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the company completed a Type A meeting ...

In an industry as dynamic as ours, it’s essential to nurture people from the very beginning, so they can shape not just their ...

Newseria nie ponosi odpowiedzialności za treści oraz inne materiały (np. infografiki, zdjęcia) przekazywane w „Biurze ...

NovartisreceivesanexclusivelicensetoanundiscloseddiscoverytargetNovartis also receives options to license two programs from Monte Rosa’s growing ...

Esophageal varices are a common and severe complication of advanced liver disease, associated with a high risk of life-threatening gastrointestinal bleeding. Their resolution in a patient with ...

Marine algae are a rich source of bioactive compounds with significant therapeutic potential, particularly in the field of cancer treatment. These bioactive ...

An exclusive on Sheridan Capital Partners acquiring National Care Systems, a revenue cycle management business focused on post-acute healthcare; a deep dive into how greater awareness about sleep care ...

Taiwan’s Vice President Bi-khim Hsiao attended the event to honor the five laureates for their exceptional achievements and ...

Progress in RNA-based medicines, immunotherapies and targeted treatments is not simply desirable, it is a critical necessity.

Kolkata: Expressing hope for a better green future of the country through holistic change in the attitude of the people of ...